In vivo activity of Sotrovimab against BQ.1.1 Omicron sublineage https://www.biorxiv.org/content/10.1101/2023.01.04.522629v1?med=mas
QOTO: Question Others to Teach Ourselves An inclusive, Academic Freedom, instance All cultures welcome. Hate speech and harassment strictly forbidden.